Showing results (251-260 of 413) with videos related to
Sort By:
Pageof 42
Annals of Surgery|March 23, 2011
Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinomaAdam C Yopp, Nora Katabi, Maria Janakos, et al.Nature Medicine|July 17, 2019
Clinical-grade computational pathology using weakly supervised deep learning on whole slide imagesGabriele Campanella, Matthew G Hanna, Luke Geneslaw, et al.Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.The American Journal of Surgical Pathology|February 7, 2022
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine TumorsMegan Parilla, David Chapel, Jaclyn F Hechtman, et al.The American Journal of Surgical Pathology|May 29, 2004
Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductulesSusanne van Eeden, Wendy W J de Leng, G Johan A Offerhaus, et al.The American Journal of Surgical Pathology|January 26, 2006
Lipid-rich variant of pancreatic endocrine neoplasmsRajendra Singh, Olca Basturk, David S Klimstra, et al.Virchows Archiv : an International Journal of Pathology|September 5, 2016
Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreasOlca Basturk, Sun M Chung, Ralph H Hruban, et al.Human Pathology|August 20, 2018
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGAJaclyn F Hechtman, Ghassan K Abou-Alfa, Zsofia K Stadler, et al.Journal of Experimental & Clinical Cancer Research : CR|May 14, 2009
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tractGeorge Miller, Nicholas D Socci, Deepti Dhall, et al.Science Advances|June 5, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomasYuxiang Wang, Aaron T Wild, Sevin Turcan, et al.Pageof 42